IP Library Granted Patent US 8,163,684
Granted Patent B2
US 8,163,684 · App. 12/055,917 · Granted Apr 24, 2012

Antimicrobials having polyquaternary ammoniums and alcohol-bearing amidoamines and methods for their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,163,684
App. No.
12/055,917
Granted
Apr 24, 2012
Kind
B2
Abstract

Antimicrobial or preservative compositions with high user comfort and/or low ocular irritation. The compositions comprise a polyquaternary ammonium compound and an amidoamine having an alcohol group and exhibit synergistic antimicrobial activity. The compositions may be used as stand-alone antimicrobials/preservatives or may be incorporated into other ocular compositions such as those for ocular lens care or the treatment of ocular conditions.

Claims (7)

1. An ophthalmic composition consisting of:

water, a surfactant, a buffer, a tonicity component, a chelating component and an antimicrobial component, wherein said antimicrobial component is a synergistically-antimicrobial amount of poly[(dimethyliminio)-2-butene-1,4-diylchloride (1:1)], a-[4-[tris(2-hydroxyethyl)ammonio]-2-buten-1-yl]-w-[tris(2-hydroxyethyl)ammonio]-chloride and an amidoamine having an alcohol group, the amidoamine having the formula R—CONCH 2 CH 2 CH 2 N(CH 3 ) 2 where R is said alcohol.

2. An ophthalmic composition according to claim 1 , wherein said poly[(dimethyliminio)-2-butene-1,4-diylchloride (1:1)], a-[4-[tris(2-hydroxyethyl)ammonio]-2-buten-1-yl]-w-[tris(2-hydroxyethyl)ammonio]-chloride is present in an amount from about 0.00001% to about 3% w/w and said amidoamine having an alcohol group is present in an amount from about 0.00001% to about 3% w/w.

3. An ophthalmic composition according to claim 1 , wherein said poly[(dimethyliminio)-2-butene-1,4-diylchloride (1:1)], a-[4-[tris(2-hydroxyethyl)ammonio]-2-buten-1-yl]-w-[tris(2-hydroxyethyl)ammonio]-chloride is present in an amount from about 0.00075 to about 1% w/w and said amidoamine having an alcohol group is present in an amount from about 0.0001% to about 1% w/w.

4. An ophthalmic composition according to claim 1 , wherein R has the formula C n H 2n+1 CH(OH)C m H 2m−2 , wherein m and n independently are integers having values of about 1 to about 18.

5. An ophthalmic composition according to claim 1 , wherein said amidoamine is ricinoleamidopropyl dimethylamine.

6. An ophthalmic composition according to claim 1 , having from about 0.00075 to about 1% w/w of poly[(dimethyliminio)-2-butene-1,4-diylchloride (1:1)], a-[4-[tris(2-hydroxyethyl)ammonio]-2-buten-1-yl]-w-[tris(2-hydroxyethyl)ammonio]-chloride and from about 0.0001% to about 1% w/w of said amidoamine wherein R has the formula C n H 2n+1 CH(OH)C m H 2m−2 , wherein m and n independently are integers having values of about 1 to about 18.

Assignments (3)
CHANGE OF NAME Recorded Sep 25, 2018
From: ABBOTT MEDICAL OPTICS INC.
To: JOHNSON & JOHNSON SURGICAL VISION, INC.
Reel/Frame 047151/0121 →
MERGER Recorded Jul 29, 2009
From: ADVANCED MEDICAL OPTICS, INC.
To: ABBOTT MEDICAL OPTICS INC.
Reel/Frame 023234/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2008
From: YU, ZHI-JIAN
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 020708/0167 →